Skip to main content
. 2014 Jan 21;55(2):344–352. doi: 10.1111/epi.12498

Table 4.

Univariate analysis for factors associated with improved therapeutic adherence adjusted for the intervention

Variable Improved (n = 29) No Improvement (n = 54) RR (95% CI) p-Value
Age: Mean (SD) 29.4 (17.8) 22.1 (13.6) 1.02 (1.00–1.03) 0.01
Sex
 Female 15 (51.7%) 24 (44.4%) 1
 Male 14 (48.3%) 30 (55.6%) 0.79 (0.44–1.43) 0.44
Injured
 No 17 (58.6%) 32 (59.3%) 1
 Yes 12 (41.4%) 22 (40.7%) 1.01 (0.56–1.84) 0.97
Educational level
 None 11 (37.9%) 21 (38.9%) 1
 Primary 16 (55.2%) 31 (57.4%) 0.97 (0.52–1.79) 0.91
 Secondary 2 (6.9) 2 (3.7%) 1.60 (0.47–5.44) 0.46
Religion
 Traditional 7 (21.2%) 26 (44.0%) 1
 Nontraditional 22 (78.8%) 28 (56.0%) 2.10 (1.00–44.40) 0.05
Learning difficulties
 No 25 (86.2%) 43 (76.6%) 1
 Yes 4 (13.8%) 11 (20.4%) 0.71 (0.28–1.82) 0.48
Neurologic deficit
 No 24 (82.8%) 49 (90.7%) 1
 Yes 5 (17.2%) 5 (9.3%) 1.59 (0.81–3.11) 0.18
 On polytherapy 6/18 (33.3%) 13/34 (38.2%) 0.82 (0.36–1.89) 0.65
Improved KEBAS: Mean (SD)
 Beliefs about causes of epilepsy 6 (20.7) 16 (29.6) 0.75 (0.35–1.61) 0.46
 Beliefs about biomedical treatment 10 (34.5) 20 (37.0) 0.98 (0.53–1.83) 0.95
 Beliefs about cultural treatment 8 (27.6) 7 (13.0) 1.02 (0.57–1.85) 0.94
 Beliefs about risks of epilepsy 15 (51.7) 27 (50.0) 1.89 (1.04–3.45) 0.04
 Stereotypes about epilepsy 22 (75.9) 30 (55.6) 1.86 (0.90–3.87) 0.10

Data are number of patients (%) except for items of KEBAS and age where we have the mean (standard deviation) of the scores. This analysis was done on 83 PWE who had nonoptimal levels of AEDs in the blood at baseline and had optimal levels of AEDs in blood at follow-up.